Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

145.50 -3.75 (-2.52%)
Streaming Delayed Price Updated: 3:32 PM EST, Nov 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
2 Small-Cap Stocks to Target This Week and 1 That Underwhelm
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Masimo Earnings Preview ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Masimo? ↗
 
Via Benzinga
News headline image
Apple Ordered To Pay $634 Million After Jury Finds Company Infringed Masimo's Blood-Oxygen Sensor Patent ↗
A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. 
Via Benzinga
Topics Intellectual Property
News headline image
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares ↗
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares 
Via The Motley Fool
News headline image
5 Insightful Analyst Questions From Masimo’s Q3 Earnings Call
Masimo’s third quarter results for 2025 were met with a significant negative market reaction, despite the company surpassing Wall Street’s revenue and adjusted profit expectations. Management... 
Via StockStory
Topics Earnings
Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature ↗
Via Stocktwits
News headline image
MASI Q3 Deep Dive: Margin Expansion and Product Pipeline Shape Outlook
Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s... 
Via StockStory
News headline image
Masimo’s (NASDAQ:MASI) Q3 Sales Top Estimates
Medical tech company Masimo (NASDAQ:MASI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 8.2% year on year to $371.5 million. The company expects the full year’s... 
Via StockStory
News headline image
Earnings To Watch: Masimo (MASI) Reports Q3 Results Tomorrow
Medical tech company Masimo (NASDAQ:MASI) will be reporting results this Tuesday after market hours. Here’s what you need to know. 
Via StockStory
News headline image
1 Unprofitable Stock with Exciting Potential and 2 We Brush Off
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
Topics Electric Vehicles
News headline image
$1000 Invested In Masimo 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
Recent Report Shows That Rep. Kevin Hern Sold Up to $200K Worth of Accenture Stock ↗
 
Via Benzinga
News headline image
DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
3 Healthcare Stocks We Think Twice About
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the... 
Via StockStory
Topics Stocks
News headline image
3 Reasons MASI is Risky and 1 Stock to Buy Instead
Over the past six months, Masimo’s shares (currently trading at $142) have posted a disappointing 17.2% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next... 
Via StockStory
Topics Stocks
News headline image
Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape
September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is... 
Via StockStory
Topics Government World Trade
News headline image
Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today ↗
Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 13.99%. Currently, Masimo has a market capitalization of... 
Via Benzinga
News headline image
3 of Wall Street’s Favorite Stocks with Questionable Fundamentals
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
1 Small-Cap Stock Worth Your Attention and 2 Facing Challenges
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
News headline image
Consumer Tech News (August 18–August 22): Powell Turns Dovish As Walmart, Target Earnings Steer Sentiment, While AI Hangover Hits Palantir ↗
Powell's dovish Jackson Hole tone, mixed WMT/TGT/TJX earnings, and an AI hangover led by PLTR's slide gave way to a late-week risk rally. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Sallie Mae, Two Harbors Investment, Flowserve, Masimo, and Select Medical Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested... 
Via StockStory
Topics Economy
News headline image
Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights ↗
Apple reintroduced blood-oxygen tracking on its watches after a Customs ruling, but Masimo has sued to block the feature again. 
Via Benzinga
Topics Intellectual Property Lawsuit
News headline image
3 Unprofitable Stocks That Fall Short
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
News headline image
Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling ↗
Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a favorable customs ruling. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.